Cáncer de hígadoFase 2NCT07223307
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
13 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Hígado y vías biliares13 estudios
Cáncer de hígadoFase 2NCT07223307
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
Carcinoma hepatocelularFase 2NCT04472767
Nivolumab, Ipilimumab, Cabozantinib, Transarterial Chemoembolization
Intrahepatic CholangiocarcinomaFase 2NCT04891289Artículos
Gemcitabine, Oxaliplatin, Dexamethasone, Floxuridine (FUDR)
Carcinoma hepatocelularFase 2NCT06789757Artículos
Memantine Hydrochloride, Bevacizumab, Atezolizumab
Intrahepatic CholangiocarcinomaFase 2NCT07766187
Histotripsy, Durvalumab, Biopsy
CholangiocarcinomaFase 2NCT05967182
Pembrolizumab, Gemcitabine, Cisplatin
Intrahepatic CholangiocarcinomaFase 2NCT06728410
Pemigatinib, Durvalumab
HCC - Hepatocellular CarcinomaFase 2NCT07586046Artículos
Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres
Locally Advanced Ampulla of Vater CarcinomaFase 2NCT07780838
Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab
Carcinoma hepatocelularFase 2NCT06526338
1.0% IP-001 for injection, Surgical Resection and Local Ablation, Local Ablation Alone
Carcinoma hepatocelular (CHC)Fase 2NCT07689175
Nivolumab, Ipilimumab (3 mg/kg)
Locally Advanced Hepatocellular CarcinomaFase 2NCT05168163
Atezolizumab, Cabozantinib, Lenvatinib
Carcinoma hepatocelularFase 2NCT05669339
Irinotecan, Sonidegib, Sorafenib